Hepwin Tablet is a pharmaceutical formulation containing L-Ornithine L-Aspartate (150 mg) and Pancreatin (100 mg), designed to support liver function and improve digestive enzyme activity. L-Ornithine L-Aspartate is an amino acid compound known for its hepatoprotective properties, primarily used to reduce elevated blood ammonia levels in patients with hepatic encephalopathy and other liver disorders. It facilitates the detoxification of ammonia by enhancing the urea cycle in the liver, thereby improving metabolic function and reducing neurotoxicity associated with liver impairment. Pancreatin, a mixture of digestive enzymes including amylase, lipase, and protease, aids in the digestion and absorption of nutrients by supplementing endogenous pancreatic enzymes, making it beneficial in conditions of pancreatic insufficiency and malabsorption syndromes. The combined action of these components in Hepwin Tablet provides a dual therapeutic effect—supporting liver detoxification and enhancing digestive efficiency. This medication is indicated for patients with chronic liver diseases, hepatic encephalopathy, and digestive enzyme deficiencies. Hepwin Tablet should be used under medical supervision, with dosage and duration tailored to individual patient needs. Contraindications include hypersensitivity to any component and caution is advised in patients with severe pancreatic or hepatic conditions.